Back to UBS Group AG UBS Group AG

SPROSPRO
Showing 8 of 29 quarters

Position history for UBS Group AGUBS Group AG's holdings in SPERO THERAPEUTICS INC

UBS Group AG holds 139,680 shares of SPRO (SPERO THERAPEUTICS INC), worth $308,693 as of 2026-Q2. The position was increased (+4542.1% shares).

Current Value

$308,693

Current Shares

139,680

Total Value Change

+$285,204

Total Shares Change

+122,151

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
139,680
+4542.1%
$308,6930.0%$2.21
26
2026-Q1
Decreased
3,009
-97.4%
$7,0410.0%$2.19
0
2025-Q4
Increased
116,447
+329.7%
$271,3220.0%$2.27
26
2025-Q3
Increased
27,101
+230.7%
$50,9500.0%$1.90
23
2025-Q2
Increased
8,194
+189.9%
$23,7630.0%$2.94
21
2025-Q1
Increased
2,826
+1904.3%
$2,0350.0%$0.77
12
2024-Q4
Decreased
141
-99.2%
$1450.0%$1.02
0
2024-Q3
Increased
17,529
+5195.8%
$23,4890.0%$1.31
21

Other major holders of SPRO: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used